NPI registry status
Active
2026 NPPES data Ambulatory Care Pharmacist NPI 1407437148
Verify on CMS → Paula Yonosko
Ambulatory Care Pharmacist in Scottsdale, Arizona.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 3,709 in Ambulatory Care Pharmacist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
907
Medicare Part D claims · 229 beneficiaries · Ambulatory Care Pharmacist avg: 526
Generic prescribing
34%
generic claims · 64% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Paula Yonosko filed 907 Medicare Part D claims in 2024 as an Ambulatory Care Pharmacist in Scottsdale, Arizona, prescribing 34% generic.
- 907
- Part D claims, 2024
- 34%
- generic prescribing
- ≥74th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Paula Yonosko
Bare NPI registry listing — limited federal enrichment beyond basic enumeration. Verify all credentials with official sources.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1407437148), first enumerated 04/15/2021.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 907 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1407437148 · Ambulatory Care Pharmacist
NPI-10 · ENUM-RECENT · TAX-NARROW · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1407437148
- ENUM-RECENT 2021
- TAX-NARROW 3,709
- RX-LIGHT 907
- BOOK-THIN 100 in Arizona
- PHOTO-ENUM Mallory Telese, PHARMD · 2021
Paula Yonosko's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
907 ≥ 74th percentile 74% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
What does the federal data show about Paula Yonosko?
Quality data not reportedPrimary specialty
Ambulatory Care Pharmacist
Medicare Part D claims
907 72% vs specialty avg
Specialty distribution in Arizona
How Ambulatory Care Pharmacist compares to other specialties among Arizona providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Ambulatory Care Pharmacist. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1407437148 |
|---|---|
| Specialty | Ambulatory Care Pharmacist |
| Gender | Female |
| NPI Issued | 04/15/2021 |
Brand vs generic prescribing mix · Brand-heavy
Paula Yonosko - brand share 64.0%
Ambulatory Care Pharmacist average
64% brand-name claims vs 34% generic, on 907 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
907
Total Claims
$618K
Total Drug Cost
229
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,808.633
- Total Day Supply
- 53,165
- Brand vs Generic
- 64% brand / 34% generic
- Brand Drug Cost
- $614K
- Generic Drug Cost
- $3K
Patient Demographics
- Average Patient Age
- 71.5 years
- Avg HCC Risk Score
- 1.69
- Gender Split
- 47% female / 53% male
- Age Distribution
- <65: 26, 65-74: 121, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Paula Yonosko prescribes most
Top Medicare Part D drugs by claim count, 2024
- Ozempic
Ozempic
157 claims
- Mounjaro
Mounjaro
93 claims
- Metformin Hcl Er 60
Metformin Hcl Er
60 claims
- Rosuvastatin Calcium 47
Rosuvastatin Calcium
47 claims
- Glipizide Er 46
Glipizide Er
46 claims
- Farxiga 42
Farxiga
42 claims
- Soliqua 100-33 38
Soliqua 100-33
38 claims
- Jardiance 36
Jardiance
36 claims
| Drug | Claims |
|---|---|
| Ozempic Semaglutide | 157 |
| Mounjaro Tirzepatide | 93 |
| Metformin Hcl Er Metformin Hcl | 60 |
| Rosuvastatin Calcium | 47 |
| Glipizide Er Glipizide | 46 |
| Farxiga Dapagliflozin Propanediol | 42 |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 38 |
| Jardiance Empagliflozin | 36 |
| Tresiba Flextouch U-100 Insulin Degludec | 34 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 33 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ambulatory Care Pharmacist Overview
How Paula Yonosko fits within the Ambulatory Care Pharmacist landscape nationally.
3,709
Ambulatory Care Pharmacist Providers in US
52
States with Ambulatory Care Pharmacist
526
Avg Claims per Provider
Paula Yonosko's 907 claims are above the specialty average of 526.
Nationwide Ambulatory Care Pharmacist peers with similar MIPS or enrollment year
Two federal-record peer sets for Yonosko, both outside Arizona so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2021)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Ambulatory Care Pharmacist Providers in Arizona
Other clinicians with the same primary specialty enrolled in Arizona, drawn from the same CMS NPPES roster as Yonosko.
One of 100 Ambulatory Care Pharmacist providers enrolled in Arizona, 5 are shown here.
Logan Abbott
Camp Verde, AZ
Dr. Anthony Albert
PHARMD
Phoenix, AZ
Tahani Almeleebia
Tucson, AZ
Dr. Collin Amundson
PHARMD
Tucson, AZ
Shimelis Areda
Winslow, AZ
Compare Ambulatory Care Pharmacist nationally: see state-by-state distribution →
Frequently Asked Questions
What is Paula Yonosko's specialty? ▼
Paula Yonosko specializes in Ambulatory Care Pharmacist and practices in Scottsdale, Arizona.
How much does Paula Yonosko prescribe under Medicare Part D? ▼
In 2024, Paula Yonosko wrote 907 Medicare Part D claims totaling $618K in drug costs for 229 beneficiaries.
Where is Paula Yonosko located? ▼
Paula Yonosko is located at 6501 E GREENWAY PKWY STE 160, Scottsdale, AZ, 85254. Phone: (480) 375-6725.
What is Paula Yonosko's NPI number? ▼
Paula Yonosko's National Provider Identifier (NPI) is 1407437148, issued on 04/15/2021.
Does Paula Yonosko prescribe more brand-name or generic drugs? ▼
Paula Yonosko's prescribing is 64% brand-name and 34% generic drugs by claim count, with $614K in brand drug costs.
How many Ambulatory Care Pharmacist providers are there in the US? ▼
There are 3,709 Ambulatory Care Pharmacist providers across 52 states in the US. The average Ambulatory Care Pharmacist provider writes 526 Medicare Part D claims per year.
What drugs does Paula Yonosko prescribe most often? ▼
Based on 2024 Medicare Part D data, Paula Yonosko's most frequently prescribed drugs include Ozempic, Mounjaro, Metformin Hcl Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Paula Yonosko accept Medicare? ▼
Paula Yonosko appears in CMS Medicare data with 907 Part D claims and 229 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Paula Yonosko's credentials? ▼
Paula Yonosko's NPI is 1407437148. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.